Allele

Allele represents one of two or more alternative forms of a gene occupying the same chromosomal position (locus), encoding variations in a specific trait or characteristic. Each individual inherits two alleles for every gene one from each parent which may be identical (homozygous) or different (heterozygous), collectively determining phenotypic expression. Allelic variation underlies genetic diversity within populations and explains individual differences in disease susceptibility, drug metabolism, and treatment response.

In precision medicine and pharmacogenomics, understanding allelic variation revolutionises therapeutic development and clinical decision-making. Specific alleles influence how patients metabolise medications through cytochrome P450 enzymes, predict adverse drug reactions, and determine efficacy of targeted therapies. For example, HLA alleles affect immune responses to biologics, while BRCA alleles guide cancer treatment selection. The biopharmaceutical industry increasingly incorporates allelic screening into clinical trial design, enabling patient stratification and identifying populations most likely to benefit from investigational therapies. Companion diagnostics often target specific allelic biomarkers, supporting regulatory approvals for personalised treatment approaches. As whole-genome sequencing becomes more accessible and affordable, comprehensive allelic profiling informs drug development strategies, regulatory submissions, and market access pathways. Companies developing cell and gene therapies must navigate complex allelic considerations in vector design, target population selection, and safety monitoring, recognising that genetic background significantly influences therapeutic outcomes.